Literature DB >> 15141275

Study of enteroparasites infection frequency and chemotherapeutic agents used in pediatric patients in a community living in Porto Alegre, RS, Brazil.

Fernanda B Morrone1, Juliana A Carneiro, Cristine dos Reis, Cibele M Cardozo, Caroline Ubal, Geraldo A de Carli.   

Abstract

Parasitic infections caused by intestinal protozoan and helminths affect more than two billion people worldwide and chemotherapy is the most commonly used therapeutic procedure. Considering the problems created by parasitic infections and the incorrect use of drugs, the aim of this work was to detect the frequency of enteroparasites infection and to estimate the use of chemotherapeutic agents in children living in the periphery of the city of Porto Alegre, RS, Brazil. Ninety-six preschool age children, who had parasitological exams and who used antiparasitic drugs, were analyzed. The efficacy of treatment was evaluated by stool examination repeated six months after treatment. The same diagnostic test was used to evaluate parasitological cure, which was defined as absence of eggs and cysts in the stool. From these children, 79 (82.3%) were contaminated by some species of parasite, the most prevalent were Ascaris lumbricoides, Trichuris trichiura and Giardia lamblia. The most commonly used drugs were mebendazole (86% of prescriptions) and metronidazole (30.3%). The cure rate in the 79 children, examined 6 months after treatment, was 65.3% for A. lumbricoides and 66.1% for T. trichiura. This study suggests that a continuous education program regarding the prevention and treatment of parasitic infections is an essential tool for their eradication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141275     DOI: 10.1590/s0036-46652004000200004

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  6 in total

1.  Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy.

Authors:  Giovani Gadonski; Carlos E Poli-de-Figueiredo; Fernando C Fervenza; Ajay K Singh; Fernando M Tettamanzy; Ivan C F Antonello; Domingos O d'Avila
Journal:  Nephron Clin Pract       Date:  2010-05-07

Review 2.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

3.  Prevalence and associated risk factors of Giardia duodenalis infection among school-going children in Nepal.

Authors:  Sarmila Tandukar; Jeevan B Sherchand; Jia Xue; Sital Uprety; Samendra P Sherchan; Dinesh Bhandari; Bikash Malla; Rajani Ghaju Shrestha; Laxmi Parajuli; Shristi Poudel; Ashmita Dhital; Eiji Haramoto
Journal:  Parasitol Res       Date:  2017-12-07       Impact factor: 2.289

4.  In vitro and ex vivo evaluation of the anti-Giardia duodenalis activity of the supernatant of Slab51 (SivoMixx).

Authors:  Stefania Perrucci; Gianluca Fichi; Enrica Ricci; Livio Galosi; Marco Lalle; Giacomo Rossi
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

5.  Update on the mapping of prevalence and intensity of infection for soil-transmitted helminth infections in Latin America and the Caribbean: a call for action.

Authors:  Martha Idalí Saboyá; Laura Catalá; Rubén Santiago Nicholls; Steven Kenyon Ault
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19

Review 6.  Prevalence of strongyloidiasis in Latin America: a systematic review of the literature.

Authors:  D Buonfrate; M A Mena; A Angheben; A Requena-Mendez; J Muñoz; F Gobbi; M Albonico; E Gotuzzo; Z Bisoffi
Journal:  Epidemiol Infect       Date:  2014-07-03       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.